Read More 1 minute read Funding News News SpliSense’s Clinical Trial Boosted by Cystic Fibrosis Foundation Key Highlights $8.5 million investment in SpliSense by the Cystic Fibrosis Foundation to advance Phase 2 clinical trials. The… byChris-Anne RoqueApril 8, 2024